Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Report Overview
Magnetic resonance imaging (MRI) utilizes radiofrequency and a strong magnetic field to generate clear and detailed images of internal organs and tissues. It is generally preferred for the diagnosis of brain and other neurological disorders. The market tracks the totality of MRI scans and does not break them down via a therapeutic setting.
The magnetic resonance imaging (MRI) contrast agents pipeline market research report covers comprehensive information about the MRI contrast agents pipeline products with a comparative analysis of the products at various stages of development. The report also includes information about the clinical trials which are in progress.
| Key Segments | · Gadolinium-Based MRI Contrast Agents
· Iron Contrast Agents · Manganese Contrast Agents · Other Paramagnetic Contrast Agents |
| Key Territories | · The US
· Europe · Japan · Canada · Australia |
| Key Regulatory Paths | · 510(k)
· CE |
| Leading Companies | · 5M Biomed LLC
· Adamas Nanotechnologies Inc · Alzeca Biosciences Inc · Antaros Medical AB · Ascelia Pharma AB |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Segments
The key segments in the MRI contrast agents pipeline market are Gadolinium-Based MRI Contrast Agents, Iron Contrast Agents, Manganese Contrast Agents, and Other Paramagnetic Contrast Agents. As of October 2024, Gadolinium-based MRI contrast agents account for the highest number of pipeline products.
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segmental Insights into the Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Segmentation by Territories
The key territories in the MRI contrast agents pipeline market are the US, Europe, Japan, Canada, and Australia, among others. As of October 2024, the US accounts for the highest number of pipeline products.
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Segmentation by Regulatory Paths
The key regulatory paths in the MRI contrast agents pipeline products market are 510(k) and CE. As of October 2024, both 510(k) and CE are the followed pathways for pipeline products in the MRI contrast agents market.
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market – Competitive Landscape
A few of the leading companies associated with the MRI contrast agents pipeline market are:
- 5M Biomed LLC
- Adamas Nanotechnologies Inc
- Alzeca Biosciences Inc
- Antaros Medical AB
- Ascelia Pharma AB
5M Biomed LLC: 5M Biomed LLC (5M Biomed) develops and delivers advanced biomedical technology to enable precision medicine. 5M Biomed is headquartered in Atlanta, Georgia, the US.
Adamas Nanotechnologies Inc.: Adamas Nanotechnologies Inc (Adamas Nanotechnologies) is a supplier of nondiamond products. Adamas Nanotechnologies is headquartered in Raleigh, North Carolina, the US.
Antaros Medical AB: Headquartered in Uppsala, Sweden, it is a drug development and technology company that offers imaging techniques for decision-making in clinical drug development. The company provides solutions including innovative, complex mechanistic studies as well as large-scale, global, and multi-center imaging trials. Its targeted therapeutic areas include cardiovascular, liver, kidney, obesity, diabetes, muscles, neuro and oncology. The company partnership with both big pharma companies and biotech’s. It has its operations in Uppsala and Gothenburg, Sweden.
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market
Segments Covered in the Report
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Segments Outlook (2024)
- Gadolinium-Based MRI Contrast Agents
- Iron Contrast Agents
- Manganese Contrast Agents
- Other Paramagnetic Contrast Agents
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Territories Outlook (2024)
- The US
- Europe
- Japan
- Canada
- Australia
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE
Scope
This report provides:
- An Extensive coverage of the MRI contrast agents under development.
- Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of MRI contrast agents and lists of all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
- Identify and understand important and diverse types of MRI contrast agents under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Adamas Nanotechnologies Inc
Alzeca Biosciences Inc
Antaros Medical AB
Ascelia Pharma AB
B-Aegis Life Sciences & Research Pvt Ltd
Bayer AG
BBS NanoTechnology Ltd
Brown University
Case Western Reserve University
EOS Biosciences Inc (Inactive)
Ferric Contrast Inc
GE HealthCare Technologies Inc
Georgia State University
Hana Pharm Co Ltd
Harvard University
Hugo W. Moser Research Institute at Kennedy Krieger Inc
IC Targets AS
Imagion Biosystems Inc
iMax Diagnostic Imaging Ltd
Indian Institute of Technology Delhi
Inlighta Biosciences LLC
Inventera Pharmaceutical Co Ltd
Iowa State University
King's College London
Knowledgepie Pvt Ltd
LadeRx LLC
Lantheus Medical Imaging Inc
Lipella Pharmaceuticals Inc
Massachusetts General Hospital
Massachusetts Institute of Technology
Molecular Theranostics LLC
Nanosion Co Ltd
National University of Singapore
Northwestern University
Polarean Imaging PLC
QurCan Therapeutics Inc
Reveal Pharmaceutical Inc
SG Endocrine Research LLC
Signablok Inc
Southern Illinois University Carbondale
SPAGO Nanomedical AB
Sree Chitra Tirunal Institute for Medical Sciences & Technology
SunTech Medical Inc
The Chinese University of Hong Kong
Theragnostic Technologies Inc
University College London
University of Arizona
University of Bordeaux
University of Chicago
University of Gottingen
University of Louisville
University of Oxford
University of Pennsylvania
University of Toronto
Videns og Forskningscenter for Alternativ Behandling
Voyageur Pharmaceuticals Ltd
Washington University in St Louis
Wayne State University
Weizmann Institute of Science
Xemed LLC
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory has the highest number of products in the MRI contrast agents pipeline market as of October 2024?
As of October 2024, the US accounts for the highest number of pipeline products in the MRI contrast agents market.
-
Which segment accounts for the highest number of pipeline products in the MRI contrast agents pipeline market as of October 2024?
As of October 2024, Gadolinium-Based MRI Contrast Agents accounts for the highest number of pipeline products in the MRI contrast agents market.
-
Which are the major companies operating in the MRI contrast agents pipeline market?
A few of the key companies associated with the MRI contrast agents pipeline market are 5M Biomed LLC, Adamas Nanotechnologies Inc, Alzeca Biosciences Inc, Antaros Medical AB, and Ascelia Pharma AB, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
